BAX-930 shows potential in patients with hereditary thrombotic thrombocytopenic purpura Dec. 28, 2016 No Comments
Helix BioPharma, ProMab Biotechnologies to establish CAR-T therapy collaboration Dec. 23, 2016 No Comments
Phase III study of emicizumab prophylaxis in hemophilia A meets primary endpoint Dec. 22, 2016 No Comments
Akebia and Otsuka Pharmaceutical collaborate to develop and commercialize vadadustat in the U.S. Dec. 21, 2016 No Comments
Kiadis obtains U.K. approvals for phase I/II trial of ATIR-201 for thalassemia Dec. 15, 2016 No Comments
RSS